Morning Briefing
Summaries of health policy coverage from major news organizations
Some Health Groups Increase Lobbying Spending, But Only A Slight Rise Overall
"Drug makers, advocacy groups, biotechnology firms and insurance companies have ratcheted up efforts to offer their two cents-and in most cases much, much more-in influencing the health care legislation now working its way through Congress," The New York Times reports.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
